Vicarious Surgical, Inc. (RBOT)
0.039
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Vicarious Surgical Research and Development Expense (TTM) : 27.99M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 27.99M |
| December 31, 2025 | 32.18M |
| September 30, 2025 | 33.24M |
| June 30, 2025 | 35.90M |
| March 31, 2025 | 37.66M |
| December 31, 2024 | 38.06M |
| September 30, 2024 | 38.08M |
| June 30, 2024 | 40.38M |
| March 31, 2024 | 42.06M |
| Date | Value |
|---|---|
| December 31, 2023 | 45.96M |
| September 30, 2023 | 49.30M |
| June 30, 2023 | 48.29M |
| March 31, 2023 | 46.27M |
| December 31, 2022 | 42.77M |
| September 30, 2022 | 40.74M |
| June 30, 2022 | 34.35M |
| March 31, 2022 | 28.30M |
| December 31, 2021 | 22.06M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Microbot Medical, Inc. | 5.82M |
| SS Innovations International, Inc. | 5.568M |
| Accuray, Inc. | 37.80M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 60.33M |